Minji Kim,1,2* Yujin Choi,1,3* Myeongcheol Lee,1,2* Jiseung Kang,4† So Min Kang,1† Dong-Geol Lee5† and Dong Keon Yon1,2,6†
1Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea
2Department of Regulatory Science, Kyung Hee University, Seoul, South Korea
3Department of Korean Medicine, Kyung Hee University College of Korean Medicine, Seoul, South Korea
4Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA
5Department of Microbiology, Dankook University, Cheonan, South Korea
6Department of Pediatrics, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea
*Minji Kim, Yujin Choi and Myeongcheol Lee contributed equally to this work.
†Jiseung Kang, So Min Kang, Dong-Geol Lee and Dong Keon Yon contributed equally to this work.
Although previous studies suggest an association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and atopic dermatitis (AD) in adults, insufficient attention has been given to the impact of such infection on pregnant woman and their offspring. Evidence on prenatal SARS-CoV-2 infection and subsequent risk of atopic dermatitis is unknown; thus, we aimed to investigate the risk of AD in the infant born to a woman infected with SARS-CoV-2 during pregnancy.